Melody A Swartz

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Science advances

Science translational medicine

Nature biomedical engineering

The Journal of experimental medicine

University of Chicago

Massachusetts Institute of Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Chicago May 01 2014

United States

William B. Ogden Professor :: Pritzger School of Molecular Engineering

Ecole Polytechnique Federale de Lausanne

Switzerland

Professor :: Institute of Bioengineering

École Polytechnique Fédérale de Lausanne

Switzerland

Associate Professor :: Institute of Bioengineering

École Polytechnique Fédérale de Lausanne

Switzerland

Assistant Professor :: Institute of Bioengineering

Northwestern University

United States

Assistant Professor :: Biomedical Engineering

Education History

Massachusetts Institute of Technology

United States

PHD :: Chemical Engineering

Johns Hopkins University

United States

BSC :: Chemical Engineering

Publications

Seounghun Kang, Aslan Mansurov, Trevin Kurtanich, Hye Rin Chun, Anna J Slezak, Lisa R Volpatti, Kevin Chang, Thomas Wang, Aaron T Alpar, Kirsten C Refvik, O Isabella Hansen, Gustavo J Borjas, Ha-Na Shim, Kevin T Hultgren, Suzana Gomes, Solanki Aniruddhsingh, Jun Ishihara, Melody A Swartz, Jeffrey A Hubbell
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Science advances 9 (48) (2023)
Priscilla S Briquez, Sherin Juliet Rouhani, Jovian Yu, Athalia R Pyzer, Jonathan A Trujillo, Haley L Dugan, Christopher T Stamper, Siriruk Changrob, Anne I Sperling, Patrick C Wilson, Thomas F Gajewski, Jeffrey A Hubbell, Melody A Swartz
Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity. Science advances 8 (40) (2022)
Maria Stella Sasso, Nikolaos Mitrousis, Yue Wang, Priscilla S Briquez, Sylvie Hauert, Jun Ishihara, Jeffrey A Hubbell, Melody A Swartz
Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas. Science advances 7 (13) (2021)
Shann S Yu, Jeffrey A Hubbell, Melody A Swartz
Overcoming transport barriers to immunotherapy. Drug delivery and translational research 11 (6) (2021)
Jun Ishihara, Ako Ishihara, Koichi Sasaki, Steve Seung-Young Lee, John-Michael Williford, Mariko Yasui, Hiroyuki Abe, Lambert Potin, Peyman Hosseinchi, Kazuto Fukunaga, Michal M Rączy, Laura T Gray, Aslan Mansurov, Kiyomitsu Katsumata, Masashi Fukayama, Stephen J Kron, Melody A Swartz, Jeffrey A Hubbell
Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science translational medicine 11 (487) (2020)
Aslan Mansurov, Jun Ishihara, Peyman Hosseinchi, Lambert Potin, Tiffany M Marchell, Ako Ishihara, John-Michael Williford, Aaron T Alpar, Michal M Raczy, Laura T Gray, Melody A Swartz, Jeffrey A Hubbell
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature biomedical engineering 4 (5) (2020)
Efthymia Vokali, Shann S Yu, Sachiko Hirosue, Marcela Rinçon-Restrepo, Fernanda V Duraes, Stefanie Scherer, Patricia Corthésy-Henrioud, Witold W Kilarski, Anna Mondino, Dietmar Zehn, Stéphanie Hugues, Melody A Swartz
Lymphatic endothelial cells prime naïve CD8+ T cells into memory cells under steady-state conditions. Nature communications 11 (1) (2020)
Ako Ishihara, Jun Ishihara, Elyse A Watkins, Andrew C Tremain, Mindy Nguyen, Ani Solanki, Kiyomitsu Katsumata, Aslan Mansurov, Erica Budina, Aaron T Alpar, Peyman Hosseinchi, Lea Maillat, Joseph W Reda, Takahiro Kageyama, Melody A Swartz, Eiji Yuba, Jeffrey A Hubbell
Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature biomedical engineering 5 (5) (2020)
John-Michael Williford, Jun Ishihara, Ako Ishihara, Aslan Mansurov, Peyman Hosseinchi, Tiffany M Marchell, Lambert Potin, Melody A Swartz, Jeffrey A Hubbell
Recruitment of CD103+ dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science advances 5 (12) (2019)
Maria A S Broggi, Lea Maillat, Cristina C Clement, Natacha Bordry, Patricia Corthésy, Aymeric Auger, Maurice Matter, Romain Hamelin, Lambert Potin, Davide Demurtas, Emanuela Romano, Alexandre Harari, Daniel E Speiser, Laura Santambrogio, Melody A Swartz
Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients. The Journal of experimental medicine 216 (5) (2019)
Jun Ishihara, Kazuto Fukunaga, Ako Ishihara, Hans M Larsson, Lambert Potin, Peyman Hosseinchi, Gabriele Galliverti, Melody A Swartz, Jeffrey A Hubbell
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science translational medicine 9 (415) (2018)
Manuel Fankhauser, Maria A S Broggi, Lambert Potin, Natacha Bordry, Laura Jeanbart, Amanda W Lund, Elodie Da Costa, Sylvie Hauert, Marcela Rincon-Restrepo, Christopher Tremblay, Elena M Cabello, Krisztian Homicsko, Olivier Michielin, Douglas Hanahan, Daniel E Speiser, Melody A Swartz
Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Science translational medicine 9 (407) (2018)

Melody A Swartz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Melody A Swartz